Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
Simone I. Richardson, Vimbai Sharon Madzorera, Holly Spencer, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 6, pp. 880-886.e4
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure
Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons, et al.
Science (2022) Vol. 377, Iss. 6603
Open Access | Times Cited: 314
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1556-1571.e18
Open Access | Times Cited: 210
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
Science (2022) Vol. 378, Iss. 6620, pp. 619-627
Open Access | Times Cited: 193
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 174
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Khadija Khan, Farina Karim, Yashica Ganga, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 156
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection
Chengzi I. Kaku, Alan Bergeron, Clas Ahlm, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 116
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2
Samantha Mackin, Pritesh Desai, Bradley Whitener, et al.
Nature Microbiology (2023) Vol. 8, Iss. 4, pp. 569-580
Open Access | Times Cited: 84
Omicron infection enhances Delta antibody immunity in vaccinated persons
Khadija Khan, Farina Karim, Sandile Cele, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 356-359
Open Access | Times Cited: 74
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
Wei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 12, pp. 1745-1758.e7
Open Access | Times Cited: 59
COVID‐19: Omicron – the latest, the least virulent, but probably not the last variant of concern of SARS‐CoV‐2
Harald Brüssow
Microbial Biotechnology (2022) Vol. 15, Iss. 7, pp. 1927-1939
Open Access | Times Cited: 54
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans
Zijun Wang, Pengcheng Zhou, Frauke Muecksch, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 12
Open Access | Times Cited: 49
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
Iris Medits, David Niklas Springer, Marianne Graninger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
When to update COVID-19 vaccine composition
Rebecca Grant, Jilian A. Sacks, Priya Abraham, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 776-780
Open Access | Times Cited: 37
Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
H. J. Yang, Weiqi Hong, Lei Hong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
Kaiyuan Sun, Stefano Tempia, Jackie Kleynhans, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 32
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
María Rescigno, Chiara Agrati, Carlo Salvarani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Estimating SARS‐CoV‐2 Omicron XBB.1.5 Spike‐Directed Functional Antibody Levels From an Anti‐Receptor Binding Domain Wuhan‐Hu‐1‐Based Commercial Immunoassay Results
Ángela Sánchez‐Simarro, Enric Cuevas‐Ferrando, Daniel Fernández‐Soto, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern
Jinal N. Bhiman, Vimbai Sharon Madzorera, Qiniso Mkhize, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Function and structure of broadly neutralizing antibodies against SARS-CoV-2 Omicron variants isolated from prototype strain infected convalescents
Dan Li, Caiqin Hu, Junwei Su, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults
Jinge Cao, Mengze Gan, Zhihao Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 262-262
Open Access
Page 1 - Next Page

Scroll to top